Metraipolis › archive › dc_9ec5ca81ed50
Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind,… — Europe PMC PMID:22293030
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/22293030
- DOI
- 10.1186/1476-511x-11-18
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T17:35:43.790Z
- SHA-256 of the archived text
9e0ffec437d10b4ad29b849dc14f74c5b816df53b34b7b9dfec6466800db009a- Stable URL of this page
https://metraipolis.com/documento/dc_9ec5ca81ed50
How to cite
Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind,… — Europe PMC PMID:22293030 — Europe PMC (en), https://europepmc.org/article/MED/22293030 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9ec5ca81ed50 (Metraipolis archive dc_9ec5ca81ed50, sha256 9e0ffec437d10b4ad29b849dc14f74c5b816df53b34b7b9dfec6466800db009a)
BibTeX
@misc{dc9ec5ca81ed50,
title = {Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind,… — Europe PMC PMID:22293030},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/22293030},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9ec5ca81ed50; sha256 9e0ffec437d10b4ad29b849dc14f74c5b816df53b34b7b9dfec6466800db009a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/22293030. Agents can read the archived copy with the MCP tool read_document.